Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund
Home - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund About Us - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Donations - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund News & Information - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Medical Information - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Supporters - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund Contact Us - Research, treatment, awareness and prevention of gynaecological cancer | GO Research Fund

Archived Go Research Fund News

DR PHILIPPA O'BRIEN AND PROF NEVILLE HACKER AWARDED FUNDS BY CANCER AUSTRALIA

Dr Philippa O’Brien and Prof Neville Hacker have been awarded approx. $600,000 over 3 years by Cancer Australia for a successful funding application under their Priority-driven Collaborative Cancer Research Scheme. The Priority-driven Collaborative Cancer Research Scheme is an innovative research funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia, and is co-endorsed by the NH&MRC. This funding is to continue our work on identifying DNA methylation markers and their application for the detection of early stage ovarian cancer.

For further info click here

back to archived news

News
Events
Newsletters
Archived News
Archived Events
  Copyright 2009 Go Research Fund | Volunteers | Privacy Policy | Sitemap
 
   
Royal Hospital For Women Foundation Link Click to go back to homepage